Case Report
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Feb 26, 2023; 11(6): 1419-1425
Published online Feb 26, 2023. doi: 10.12998/wjcc.v11.i6.1419
Transverse myelitis caused by herpes zoster following COVID-19 vaccination: A case report
Su-Yeon Cho, Bo-Hyun Jang, Jun-Won Seo, Suk-Whee Kim, Kyung-Joon Lim, Hyun-Young Lee, Dong-Joon Kim
Su-Yeon Cho, Bo-Hyun Jang, Suk-Whee Kim, Department of Anesthesiology and Pain Medicine, Chosun University Hospital, Gwangju 61453, South Korea
Jun-Won Seo, Department of Internal Medicine, Chosun University, College of Medicine, Gwangju 61453, South Korea
Kyung-Joon Lim, Hyun-Young Lee, Dong-Joon Kim, Department of Anesthesiology and Pain Medicine, Chosun University, College of Medicine, Gwangju 61453, South Korea
Author contributions: Lee HY conceived the article; Kim SW and Kim DJ collected the data; Seo JW and Lee HY assembled the data; Cho SY, Seo JW, Kim SW, Lim KJ, Lee HY, Kim DJ provided the study materials, write the manuscript and approved the manuscript.
Supported by Research fund from Chosun University Hospital, 2022.
Informed consent statement: Informed written consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Dong-Joon Kim, MD, PhD, Associate Professor, Department of Anesthesiology and Pain Medicine, Chosun University, College of Medicine, Pilmun-daero 365, Gwangju 61453, South Korea. djkim@chosun.ac.kr
Received: November 30, 2022
Peer-review started: November 30, 2022
First decision: January 17, 2023
Revised: January 17, 2023
Accepted: February 3, 2023
Article in press: February 3, 2023
Published online: February 26, 2023
Core Tip

Core Tip: Reports are increasing that transverse myelitis (TM) is a rare herpes zoster (HZ) complication and is linked to coronavirus disease 2019 (COVID-19) vaccines. HZ following the COVID-19 vaccination may lead to more severe complications due to the vaccine immunocompromising the patient. Typically, complications like TM from HZ may be rare, and difficult to diagnose. If there is diagnosis confusion, TM will progress rapidly, delaying the appropriate treatment. A critical point is to implement appropriate HZ therapy without delay simultaneously with neurological examination to evaluate TM progress and treatment and HZ care with pain control to protect against complications like postherpetic neuralgia.